Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $828.2300 (0.45%) ($828.2300 - $828.2300) on Thu. Apr. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.89% (three month average) | RSI | 82 | Latest Price | $828.2300(0.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.4% a day on average for past five trading days. | Weekly Trend | REGN advances 3.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(48%) XLV(46%) DIA(35%) VYM(33%) IWD(32%) | Factors Impacting REGN price | REGN will decline at least -0.945% in a week (0% probabilities). VXX(-29%) VIXM(-22%) TBT(-5%) UUP(-4%) SMH(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.945% (StdDev 1.89%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $824.27(0.48%) | 10 Day Moving Average | $821.8(0.78%) | 20 Day Moving Average | $792.46(4.51%) | To recent high | 0% | To recent low | 21.7% | Market Cap | $87.816b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |